サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1545562

生殖補助医療の世界市場

Assisted Reproductive Technology

出版日
ページ情報
英文 179 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
生殖補助医療の世界市場
出版日: 2024年09月02日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 179 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

生殖補助医療の世界市場は2030年までに276億米ドルに達する見込み

2023年に197億米ドルと推定される生殖補助医療の世界市場は、2030年には276億米ドルに達し、分析期間2023-2030年のCAGRは4.9%で成長すると予測されます。本レポートで分析したセグメントの1つである体外受精（IVF）は、CAGR 5.0％を記録し、分析期間終了までに220億米ドルに達すると予測されます。凍結胚交換（FER）分野の成長率は、分析期間のCAGRで4.5％と推定されます。

米国市場は53億米ドルと推定、中国はCAGR4.8％で成長予測

米国の生殖補助医療市場は2023年に53億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに44億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは4.8%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ4.6%と3.8%と予測されています。欧州では、ドイツがCAGR 4.0%で成長すると予測されています。

世界の生殖補助医療市場- 主要動向と促進要因のまとめ

生殖補助医療は現代の不妊治療をどのように変革しているか？

生殖補助医療（ART）は、不妊治療の分野に革命をもたらし、不妊に悩む何百万もの個人やカップルに希望をもたらしています。ARTは、不妊症の治療に用いられるさまざまな医療行為を包含しており、体外受精（IVF）は最もよく知られ、広く用いられている方法です。これらの技術は、妊娠を達成するために卵子、精子、胚を操作するもので、自然妊娠の課題に直面している人々に新たな可能性をもたらしました。卵細胞質内精子注入法（ICSI）、着床前遺伝学的検査（PGT）、卵子凍結などの技術の向上により、成功率は飛躍的に高まり、患者の選択肢も広がった。ARTがより洗練されるにつれ、生殖医療で可能なことの限界を押し広げ続け、それぞれの患者のユニークなニーズに応える個別化されたソリューションを提供しています。

ARTの成功率を高める技術革新とは？

技術革新は、生殖補助医療の成功率を高め、これらの治療をより身近で効果的なものにする上で重要な役割を果たしています。タイムラプス画像や人工知能（AI）を用いた胚の品質評価など、胚培養技術の進歩は、移植に最も生存可能な胚を選択する能力を向上させ、妊娠成功の可能性を高めています。また、より洗練されたホルモン刺激プロトコルの開発により、卵巣過剰刺激症候群（OHSS）のリスクが減少し、体外受精を受ける患者の転帰が改善されました。さらに、凍結保存の技術革新、特にガラス化技術により、凍結卵子や凍結胚の生存率が大幅に向上し、より柔軟な治療スケジュールと生殖能力の保存が可能になりました。こうした技術の進歩は、成功率を高めるだけでなく、複雑な不妊症の患者や出産を遅らせたい患者など、より幅広い患者にとってARTをより信頼できる選択肢にしています。

どのような市場動向が生殖補助医療の採用を促進しているのか？

生殖補助医療の普及を後押ししているのは、家族計画や生殖医療の進歩に対する社会的な考え方の変化を反映した、いくつかの重要な市場動向です。キャリアの優先順位や社会規範の変化により、親になる時期を遅らせる傾向が強まっているため、卵子凍結のような妊孕性温存のオプションに対する需要が高まっています。さらに、同性カップルやシングルペアレントの間でARTに対する認識が高まり、受け入れられるようになったことで、不妊治療市場が拡大しています。医療ツーリズムの成長、特にARTがより手頃な価格で受けられる国や特定の治療がより容易に受けられる国も、ARTサービスの世界的拡大に寄与しています。さらに、患者固有のニーズや状況に沿ったオーダーメイドの治療計画を求める患者が増加しているため、個別化医療への流れがART市場に影響を与えています。

生殖補助医療市場の成長を促進する要因とは？

生殖補助医療市場の成長は、不妊治療の状況を変えつつあるいくつかの要因によって牽引されています。主な要因としては、出産の遅れ、ライフスタイルの変化、生殖の健康に影響を与える環境要因などの影響による不妊症の有病率の増加が挙げられます。胚の選択、凍結保存、遺伝子検査などの改良を含むARTの技術的進歩は、成功率を高め、より幅広い患者にこれらの治療の魅力を広げています。また、不妊治療へのアクセスが普及しつつある新興市場におけるARTサービスの拡大も、市場の成長に寄与しています。さらに、子作りの遅れや家族計画の柔軟性を求める動向などを背景に、妊孕性温存の選択肢に対する需要が高まっていることも、ARTの導入を後押ししています。こうした要因が進化を続ける中、ART市場は、技術革新、社会規範の変化、効果的な不妊治療ソリューションへのニーズの高まりによって、持続的な成長が見込まれます。

調査対象企業の例（全11件）

  • Bloom Fertility Centre
  • Cosmos Biomedical Ltd.
  • Cryolab Ltd.
  • European Sperm Bank ApS
  • Ferring Pharmaceuticals
  • Irvine Scientific
  • Microm UK Ltd
  • ORIGIO A/S
  • Ovascience Inc.
  • Parallabs Limited

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP10397

Global Assisted Reproductive Technology Market to Reach US$27.6 Billion by 2030

The global market for Assisted Reproductive Technology estimated at US$19.7 Billion in the year 2023, is expected to reach US$27.6 Billion by 2030, growing at a CAGR of 4.9% over the analysis period 2023-2030. In-Vitro Fertilization (IVF), one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$22.0 Billion by the end of the analysis period. Growth in the Frozen Embryo Replacement (FER) segment is estimated at 4.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$5.3 Billion While China is Forecast to Grow at 4.8% CAGR

The Assisted Reproductive Technology market in the U.S. is estimated at US$5.3 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$4.4 Billion by the year 2030 trailing a CAGR of 4.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.6% and 3.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.0% CAGR.

Global Assisted Reproductive Technology Market - Key Trends and Drivers Summarized

How Is Assisted Reproductive Technology Transforming Modern Fertility Treatments?

Assisted Reproductive Technology (ART) has revolutionized the field of fertility treatments, offering hope to millions of individuals and couples struggling with infertility. ART encompasses a range of medical procedures used to treat infertility, with in vitro fertilization (IVF) being the most well-known and widely used method. These technologies involve the manipulation of eggs, sperm, or embryos to achieve pregnancy, and have opened up new possibilities for those facing challenges in conceiving naturally. ART has advanced significantly since its inception, with improvements in techniques such as intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and egg freezing, which have dramatically increased success rates and expanded the options available to patients. As ART becomes more sophisticated, it continues to push the boundaries of what is possible in reproductive medicine, providing personalized solutions that cater to the unique needs of each patient.

What Technological Innovations Are Enhancing the Success Rates of ART?

Technological innovations have played a critical role in enhancing the success rates of Assisted Reproductive Technology, making these treatments more accessible and effective. Advances in embryo culture techniques, such as time-lapse imaging and the use of artificial intelligence (AI) to assess embryo quality, have improved the ability to select the most viable embryos for transfer, increasing the likelihood of a successful pregnancy. The development of more refined hormonal stimulation protocols has also reduced the risk of ovarian hyperstimulation syndrome (OHSS) and improved outcomes for patients undergoing IVF. Additionally, innovations in cryopreservation, particularly vitrification, have significantly improved the survival rates of frozen eggs and embryos, allowing for more flexible treatment schedules and better preservation of reproductive potential. These technological advancements are not only boosting success rates but also making ART a more reliable option for a broader range of patients, including those with complex infertility issues or those who wish to delay childbearing.

What Market Trends Are Driving the Adoption of Assisted Reproductive Technology?

Several key market trends are driving the adoption of Assisted Reproductive Technology, reflecting broader changes in societal attitudes towards family planning and advancements in reproductive medicine. The increasing trend towards delayed parenthood, driven by career priorities and changing social norms, has led to a growing demand for fertility preservation options such as egg freezing, which is now often included as part of ART services. Additionally, the rising awareness and acceptance of ART among same-sex couples and single parents have expanded the market for fertility treatments, as these groups seek options to build their families. The growth of medical tourism, particularly in countries where ART is more affordable or where certain treatments are more readily available, is also contributing to the global expansion of ART services. Furthermore, the ongoing trend towards personalized medicine is influencing the ART market, as patients increasingly seek tailored treatment plans that align with their specific needs and circumstances.

What Factors Are Driving the Growth of the Assisted Reproductive Technology Market?

The growth in the Assisted Reproductive Technology market is driven by several factors that are reshaping the landscape of fertility treatments. A primary driver is the increasing prevalence of infertility, influenced by factors such as delayed childbearing, lifestyle changes, and environmental factors that impact reproductive health. Technological advancements in ART, including improvements in embryo selection, cryopreservation, and genetic testing, are enhancing success rates and broadening the appeal of these treatments to a wider range of patients. The expansion of ART services in emerging markets, where access to fertility treatments is becoming more widespread, is also contributing to market growth. Additionally, the rise in demand for fertility preservation options, driven by trends such as delayed parenthood and the desire for family planning flexibility, is boosting the adoption of ART. As these factors continue to evolve, the ART market is expected to experience sustained growth, driven by innovation, changing societal norms, and the increasing need for effective fertility solutions.

Select Competitors (Total 11 Featured) -

  • Bloom Fertility Centre
  • Cosmos Biomedical Ltd.
  • Cryolab Ltd.
  • European Sperm Bank ApS
  • Ferring Pharmaceuticals
  • Irvine Scientific
  • Microm UK Ltd
  • ORIGIO A/S
  • Ovascience Inc.
  • Parallabs Limited

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Assisted Reproductive Technology - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Infertility Rates Propel Growth in Assisted Reproductive Technology
    • Advancements in Embryo Selection Strengthen Business Case for ART
    • Increasing Demand for Egg Freezing Expands Addressable Market Opportunity
    • Shift Towards Delayed Parenthood Spurs Growth in Fertility Preservation Services
    • Growth in Same-Sex Couple Family Planning Drives Adoption of ART
    • Innovation in Genetic Testing Techniques Accelerates Demand for Tailored ART Solutions
    • Rising Acceptance of ART Among Single Parents Expands Market Reach
    • Global Medical Tourism Throws the Spotlight on Affordable ART Options
    • Improvement in Cryopreservation Techniques Sustains Growth in ART Market
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Fertility Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Fertility Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Fertility Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 7: World Assisted Reproductive Technology Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Assisted Reproductive Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Assisted Reproductive Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for In-Vitro Fertilization (IVF) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for In-Vitro Fertilization (IVF) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for In-Vitro Fertilization (IVF) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Frozen Embryo Replacement (FER) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Frozen Embryo Replacement (FER) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Frozen Embryo Replacement (FER) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Artificial Insemination-Intrauterine Insemination (AI-IUI) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Artificial Insemination-Intrauterine Insemination (AI-IUI) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Artificial Insemination-Intrauterine Insemination (AI-IUI) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Fresh Non-Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Fresh Non-Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Fresh Non-Donor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Frozen Non-Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Frozen Non-Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Frozen Non-Donor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Embryo / Egg Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Embryo / Egg Banking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Embryo / Egg Banking by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Frozen Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Frozen Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: World 16-Year Perspective for Frozen Donor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Fresh Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Fresh Donor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: World 16-Year Perspective for Fresh Donor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Assisted Reproductive Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: USA 16-Year Perspective for Assisted Reproductive Technology by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: USA 16-Year Perspective for Assisted Reproductive Technology by Type - Percentage Breakdown of Value Sales for In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types for the Years 2014, 2024 & 2030
    • TABLE 47: USA Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: USA Historic Review for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: USA 16-Year Perspective for Assisted Reproductive Technology by Procedure - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Canada 16-Year Perspective for Assisted Reproductive Technology by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Canada 16-Year Perspective for Assisted Reproductive Technology by Type - Percentage Breakdown of Value Sales for In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types for the Years 2014, 2024 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Canada 16-Year Perspective for Assisted Reproductive Technology by Procedure - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor for the Years 2014, 2024 & 2030
  • JAPAN
    • Assisted Reproductive Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: Japan 16-Year Perspective for Assisted Reproductive Technology by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Japan 16-Year Perspective for Assisted Reproductive Technology by Type - Percentage Breakdown of Value Sales for In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types for the Years 2014, 2024 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Japan 16-Year Perspective for Assisted Reproductive Technology by Procedure - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor for the Years 2014, 2024 & 2030
  • CHINA
    • Assisted Reproductive Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 68: China Recent Past, Current & Future Analysis for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: China 16-Year Perspective for Assisted Reproductive Technology by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: China 16-Year Perspective for Assisted Reproductive Technology by Type - Percentage Breakdown of Value Sales for In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types for the Years 2014, 2024 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: China 16-Year Perspective for Assisted Reproductive Technology by Procedure - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor for the Years 2014, 2024 & 2030
  • EUROPE
    • Assisted Reproductive Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: Europe 16-Year Perspective for Assisted Reproductive Technology by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Assisted Reproductive Technology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Europe 16-Year Perspective for Assisted Reproductive Technology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Europe 16-Year Perspective for Assisted Reproductive Technology by Type - Percentage Breakdown of Value Sales for In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types for the Years 2014, 2024 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Europe 16-Year Perspective for Assisted Reproductive Technology by Procedure - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor for the Years 2014, 2024 & 2030
  • FRANCE
    • Assisted Reproductive Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 89: France Recent Past, Current & Future Analysis for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: France 16-Year Perspective for Assisted Reproductive Technology by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: France 16-Year Perspective for Assisted Reproductive Technology by Type - Percentage Breakdown of Value Sales for In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types for the Years 2014, 2024 & 2030
    • TABLE 95: France Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: France Historic Review for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: France 16-Year Perspective for Assisted Reproductive Technology by Procedure - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor for the Years 2014, 2024 & 2030
  • GERMANY
    • Assisted Reproductive Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Germany 16-Year Perspective for Assisted Reproductive Technology by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Germany 16-Year Perspective for Assisted Reproductive Technology by Type - Percentage Breakdown of Value Sales for In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types for the Years 2014, 2024 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Germany Historic Review for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Germany 16-Year Perspective for Assisted Reproductive Technology by Procedure - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Italy 16-Year Perspective for Assisted Reproductive Technology by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Italy 16-Year Perspective for Assisted Reproductive Technology by Type - Percentage Breakdown of Value Sales for In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types for the Years 2014, 2024 & 2030
    • TABLE 113: Italy Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Italy Historic Review for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Italy 16-Year Perspective for Assisted Reproductive Technology by Procedure - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Assisted Reproductive Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 116: UK Recent Past, Current & Future Analysis for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: UK 16-Year Perspective for Assisted Reproductive Technology by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: UK 16-Year Perspective for Assisted Reproductive Technology by Type - Percentage Breakdown of Value Sales for In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types for the Years 2014, 2024 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: UK Historic Review for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: UK 16-Year Perspective for Assisted Reproductive Technology by Procedure - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Europe 16-Year Perspective for Assisted Reproductive Technology by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Europe 16-Year Perspective for Assisted Reproductive Technology by Type - Percentage Breakdown of Value Sales for In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types for the Years 2014, 2024 & 2030
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Assisted Reproductive Technology by Procedure - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Assisted Reproductive Technology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Asia-Pacific 16-Year Perspective for Assisted Reproductive Technology by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Asia-Pacific 16-Year Perspective for Assisted Reproductive Technology by Type - Percentage Breakdown of Value Sales for In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types for the Years 2014, 2024 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Assisted Reproductive Technology by Procedure - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Assisted Reproductive Technology by End-Use - Fertility Clinics, Hospitals and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Rest of World 16-Year Perspective for Assisted Reproductive Technology by End-Use - Percentage Breakdown of Value Sales for Fertility Clinics, Hospitals and Other End-Uses for the Years 2014, 2024 & 2030
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Rest of World Historic Review for Assisted Reproductive Technology by Type - In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Rest of World 16-Year Perspective for Assisted Reproductive Technology by Type - Percentage Breakdown of Value Sales for In-Vitro Fertilization (IVF), Frozen Embryo Replacement (FER), Artificial Insemination-Intrauterine Insemination (AI-IUI) and Other Types for the Years 2014, 2024 & 2030
    • TABLE 149: Rest of World Recent Past, Current & Future Analysis for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Rest of World Historic Review for Assisted Reproductive Technology by Procedure - Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Rest of World 16-Year Perspective for Assisted Reproductive Technology by Procedure - Percentage Breakdown of Value Sales for Fresh Non-Donor, Frozen Non-Donor, Embryo / Egg Banking, Frozen Donor and Fresh Donor for the Years 2014, 2024 & 2030

IV. COMPETITION